Lumen teams up with Google to improve manufacturing productivity
Lumen applies machine learning to increase biomanufacturing productivity of its spirulina-based biologic drugs.
Lumen applies machine learning to increase biomanufacturing productivity of its spirulina-based biologic drugs.
There is “sizable demand” from manufacturers of COVID-19 vaccines for vials out to 2023, suggesting that the market will remain significant for some time.
The European Medicines Agency (EMA) has reminded manufacturers of COVID-19 vaccines of their safety reporting obligations.
The European Directorate for the Quality of Medicines (EDQM) has released a draft monograph on the anti-TNF-alpha antibody golimumab for consultation.
CureVac and GSK said their jointly advanced second-generation mRNA COVID-19 vaccine candidate, CV2CoV, demonstrated improved immune response and protection in a preclinical study.